These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12466040)

  • 1. Emotional blunting, sexual dysfunction and SSRIs.
    Balon R
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):415-6; author reply 417. PubMed ID: 12466040
    [No Abstract]   [Full Text] [Related]  

  • 2. Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?
    Opbroek A; Delgado PL; Laukes C; McGahuey C; Katsanis J; Moreno FA; Manber R
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):147-51. PubMed ID: 12135539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study.
    Stryjer R; Spivak B; Strous RD; Shiloh R; Harary E; Polak L; Birgen M; Kotler M; Weizman A
    Clin Neuropharmacol; 2009; 32(2):82-4. PubMed ID: 18978492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin Selective Reuptake Inhibitors (SSRIs) and Female Sexual Dysfunction (FSD): Hypothesis on its Association and Options of Treatment.
    Rappek NAM; Sidi H; Kumar J; Kamarazaman S; Das S; Masiran R; Baharuddin N; Hatta MH
    Curr Drug Targets; 2018; 19(12):1352-1358. PubMed ID: 28025939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does sexual dysfunction persist upon discontinuation of selective serotonin reuptake inhibitors?].
    Ekhart GC; van Puijenbroek EP
    Tijdschr Psychiatr; 2014; 56(5):336-40. PubMed ID: 24838589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies.
    Simonsen AL; Danborg PB; Gøtzsche PC
    Int J Risk Saf Med; 2016 Mar; 28(1):1-12. PubMed ID: 27176752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitor-induced sexual dysfunction.
    Corona G; Ricca V; Bandini E; Mannucci E; Lotti F; Boddi V; Rastrelli G; Sforza A; Faravelli C; Forti G; Maggi M
    J Sex Med; 2009 May; 6(5):1259-69. PubMed ID: 19473282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSRIs, bupropion, and sexual function.
    Edens N; Newton WP
    J Fam Pract; 1997 Aug; 45(2):101-2. PubMed ID: 9267363
    [No Abstract]   [Full Text] [Related]  

  • 9. A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors?
    Patacchini A; Cosci F
    J Clin Psychopharmacol; 2020; 40(1):93-95. PubMed ID: 31834096
    [No Abstract]   [Full Text] [Related]  

  • 10. Sexual dysfunction and selective serotonin reuptake inhibitors.
    Gagnon M; Layton S; Messier C
    Biol Psychiatry; 1998 Sep; 44(5):374. PubMed ID: 9755362
    [No Abstract]   [Full Text] [Related]  

  • 11. Forum: what are the best ways to treat sexual problems caused by SSRIs?
    Thompson TL
    Harv Ment Health Lett; 1999 Nov; 16(5):8. PubMed ID: 10521911
    [No Abstract]   [Full Text] [Related]  

  • 12. Vortioxetine-induced manic mood switch in patient with previously unknown bipolar disorder.
    Sobreira G; Oliveira J; Brissos S
    Braz J Psychiatry; 2017; 39(1):86. PubMed ID: 28273272
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-SSRI Sexual Dysfunction: Preclinical to Clinical. Is It Fact or Fiction?
    Coskuner ER; Culha MG; Ozkan B; Kaleagasi EO
    Sex Med Rev; 2018 Apr; 6(2):217-223. PubMed ID: 29463440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent sexual dysfunction in genitourinary medicine clinic attendees induced by selective serotonin reuptake inhibitors.
    Farnsworth KD; Dinsmore WW
    Int J STD AIDS; 2009 Jan; 20(1):68-9. PubMed ID: 19103903
    [No Abstract]   [Full Text] [Related]  

  • 15. Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors.
    Shrivastava RK; Shrivastava S; Overweg N; Schmitt M
    J Clin Psychopharmacol; 1995 Feb; 15(1):83-4. PubMed ID: 7714234
    [No Abstract]   [Full Text] [Related]  

  • 16. Making advances where it matters: improving outcomes in mood and anxiety disorders.
    Golden RN
    CNS Spectr; 2004 Jun; 9(6 Suppl 4):14-22. PubMed ID: 15181381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
    Ahrold TK; Meston CM
    J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey.
    Williams VS; Edin HM; Hogue SL; Fehnel SE; Baldwin DS
    J Psychopharmacol; 2010 Apr; 24(4):489-96. PubMed ID: 19329551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
    Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
    World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing common Side effects of SSRIs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Feb; 45(2):15-8. PubMed ID: 17334198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.